海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
195件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Multi center, double blind, randomized, placebo controlled, active reference, parallel group polysomnography study to assess the efficacy and safety of a 16 day oral administration of ACT 078573 in adult subjects with chronic primary insomnia.
- Chronic primary insomnia MedDRA version: 9.1 Level: LLT Classification code 10022437 Term: Insomnia
- Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Slovakia, Spain, Sweden, United Kingdom
- 2008-05-06
Not recruiting
- A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)
- Partial Onset Seizures
- Austria, Denmark, Germany, Norway, Sweden
- 2013-04-10
Not Recruiting
- A study to assess the efficacy and safety of Dupilumab in patients with severe atopic dermatitis (AD) that are not controlled with oral cyclosporine A (CSA) or for those who cannot take oral CSA because it is not medically advisable
- Atopic dermatitis MedDRA version: 19.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Russian Federation, Slovakia, Spain, United Kingdom
- 2015-09-24
Not recruiting
- Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
- Dyskinesia;Levodopa-Induced Dyskinesia (LID);Parkinson's Disease (PD)
- Austria, France, Germany, Spain, United States
- 2014-10-22
Not recruiting
- Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Canada, Czech Republic, Czechia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Latvia, Netherlands, New Zealand, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2014-10-06
Not Recruiting
- A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
- Urinary Bladder Overactive # Urinary Bladder Diseases # Urologic Diseases;N32.8 - Other specified disorders of bladder
- Armenia, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States
- 2015-04-20
Not Recruiting
- CLINICAL STUDY OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNE GLOBULIN, 20% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
- Primary Immunodeficiency Diseases MedDRA version: 16.1 Level: PT Classification code 10064859 Term: Primary immunodeficiency syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Austria, Belgium, Germany, Hungary, Netherlands, Sweden, United Kingdom
- 2010-07-28
Not Recruiting
- A prospective outcome study on patients with profound combined immunodeficiency
- ;D83.1 - Common variable immunodeficiency with predominant immunoregulatory T-cell disorders;C91.5 - Adult T-cell leukaemia
- Austria, Canada, Czech Republic, France, Germany, Israel, Italy, Kuwait, Netherlands, Poland, Slovenia, Spain, Switzerland, United Kingdom, United States
- 2011-07-26
Not recruiting
- Safety and Tolerability of REGN668 (SAR231893) in Patients With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Australia, Germany, New Zealand
- 2011-06-09
Not Recruiting
- A clinical trial to study the safety and efficacy of the study drug when added to atorvastatin plus standard of care in subjects with Acute Coronary syndromes (ACS).
- Acute Coronary Syndromes
- Australia, Canada, Czech Republic, Georgia, Germany, Hungary, India, Italy, Lebanon, Netherlands, New Zealand, Poland, Russian Federation, Spain, Ukraine, United States of America
- 2011-05-05